APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Neurorehabilitation Biofeedback Therapy Device

Compare research editions
View pricing & licenses

Selected research

Industry Research

Medical Neurorehabilitation Biofeedback Therapy Device Industry Research Report 2026

24 December 2025121 pages

Choose your research edition.

Industry ResearchMedical Neurorehabilitation Biofeedback Therapy Device Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Neurorehabilitation Biofeedback Therapy Device Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Medical Neurorehabilitation Biofeedback Therapy Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Neurorehabilitation Biofeedback Therapy Device Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Neurorehabilitation Biofeedback Therapy Device Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Medical Neurorehabilitation Biofeedback Therapy Device market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Medical Neurorehabilitation Biofeedback Therapy Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Medical Neurorehabilitation Biofeedback Therapy Device is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Medical Neurorehabilitation Biofeedback Therapy Device is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Medical Neurorehabilitation Biofeedback Therapy Device include Roche, Abbott, ARKRAY, Ascensia, B. Braun, BIONIME, GMMC Group, Lifescan and Sinocare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Medical Neurorehabilitation Biofeedback Therapy Device market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Medical Neurorehabilitation Biofeedback Therapy Device Market by Company

Roche

Abbott

ARKRAY

Ascensia

B. Braun

BIONIME

GMMC Group

Lifescan

Sinocare

TERUMO

LIANFA

Lobeck Medical AG

Medical Neurorehabilitation Biofeedback Therapy Device Segment by Type

Conventional

Intelligent

Medical Neurorehabilitation Biofeedback Therapy Device Segment by Application

Hospital

Clinic

Others

Medical Neurorehabilitation Biofeedback Therapy Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Neurorehabilitation Biofeedback Therapy Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Neurorehabilitation Biofeedback Therapy Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Neurorehabilitation Biofeedback Therapy Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Medical Neurorehabilitation Biofeedback Therapy Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Medical Neurorehabilitation Biofeedback Therapy Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Medical Neurorehabilitation Biofeedback Therapy Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Medical Neurorehabilitation Biofeedback Therapy Device Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Medical Neurorehabilitation Biofeedback Therapy Device Sales (Units) of Manufacturers (2021-2026) Table 7. Global Medical Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Manufacturers (2021-2026) Table 8. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue of Manufacturers (2021-2026) Table 9. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Medical Neurorehabilitation Biofeedback Therapy Device Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Medical Neurorehabilitation Biofeedback Therapy Device Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Medical Neurorehabilitation Biofeedback Therapy Device, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Medical Neurorehabilitation Biofeedback Therapy Device, Product Type & Application Table 14. Global Medical Neurorehabilitation Biofeedback Therapy Device Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Medical Neurorehabilitation Biofeedback Therapy Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Roche Company Information Table 19. Roche Business Overview Table 20. Roche Medical Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Roche Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 22. Roche Recent Developments Table 23. Abbott Company Information Table 24. Abbott Business Overview Table 25. Abbott Medical Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Abbott Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 27. Abbott Recent Developments Table 28. ARKRAY Company Information Table 29. ARKRAY Business Overview Table 30. ARKRAY Medical Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. ARKRAY Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 32. ARKRAY Recent Developments Table 33. Ascensia Company Information Table 34. Ascensia Business Overview Table 35. Ascensia Medical Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Ascensia Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 37. Ascensia Recent Developments Table 38. B. Braun Company Information Table 39. B. Braun Business Overview Table 40. B. Braun Medical Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. B. Braun Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 42. B. Braun Recent Developments Table 43. BIONIME Company Information Table 44. BIONIME Business Overview Table 45. BIONIME Medical Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. BIONIME Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 47. BIONIME Recent Developments Table 48. GMMC Group Company Information Table 49. GMMC Group Business Overview Table 50. GMMC Group Medical Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. GMMC Group Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 52. GMMC Group Recent Developments Table 53. Lifescan Company Information Table 54. Lifescan Business Overview Table 55. Lifescan Medical Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Lifescan Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 57. Lifescan Recent Developments Table 58. Sinocare Company Information Table 59. Sinocare Business Overview Table 60. Sinocare Medical Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Sinocare Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 62. Sinocare Recent Developments Table 63. TERUMO Company Information Table 64. TERUMO Business Overview Table 65. TERUMO Medical Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. TERUMO Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 67. TERUMO Recent Developments Table 68. LIANFA Company Information Table 69. LIANFA Business Overview Table 70. LIANFA Medical Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. LIANFA Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 72. LIANFA Recent Developments Table 73. Lobeck Medical AG Company Information Table 74. Lobeck Medical AG Business Overview Table 75. Lobeck Medical AG Medical Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Lobeck Medical AG Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 77. Lobeck Medical AG Recent Developments Table 78. Global Medical Neurorehabilitation Biofeedback Therapy Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Medical Neurorehabilitation Biofeedback Therapy Device Sales by Region (2021-2026) & (Units) Table 80. Global Medical Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Region (2021-2026) Table 81. Global Medical Neurorehabilitation Biofeedback Therapy Device Sales by Region (2027-2032) & (Units) Table 82. Global Medical Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Region (2027-2032) Table 83. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Region (2021-2026) Table 85. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Region (2027-2032) Table 87. North America Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Medical Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2026) & (Units) Table 89. North America Medical Neurorehabilitation Biofeedback Therapy Device Sales by Country (2027-2032) & (Units) Table 90. North America Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Medical Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2026) & (Units) Table 94. Europe Medical Neurorehabilitation Biofeedback Therapy Device Sales by Country (2027-2032) & (Units) Table 95. Europe Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Medical Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2026) & (Units) Table 99. Asia Pacific Medical Neurorehabilitation Biofeedback Therapy Device Sales by Country (2027-2032) & (Units) Table 100. Asia Pacific Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Medical Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2026) & (Units) Table 104. South America Medical Neurorehabilitation Biofeedback Therapy Device Sales by Country (2027-2032) & (Units) Table 105. South America Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Medical Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2026) & (Units) Table 109. Middle East and Africa Medical Neurorehabilitation Biofeedback Therapy Device Sales by Country (2027-2032) & (Units) Table 110. Middle East and Africa Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Medical Neurorehabilitation Biofeedback Therapy Device Sales by Type (2021-2026) & (Units) Table 113. Global Medical Neurorehabilitation Biofeedback Therapy Device Sales by Type (2027-2032) & (Units) Table 114. Global Medical Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Type (2021-2026) Table 115. Global Medical Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Type (2027-2032) Table 116. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Type (2021-2026) Table 119. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Type (2027-2032) Table 120. Global Medical Neurorehabilitation Biofeedback Therapy Device Price by Type (2021-2026) & (US$/Unit) Table 121. Global Medical Neurorehabilitation Biofeedback Therapy Device Price by Type (2027-2032) & (US$/Unit) Table 122. Global Medical Neurorehabilitation Biofeedback Therapy Device Sales by Application (2021-2026) & (Units) Table 123. Global Medical Neurorehabilitation Biofeedback Therapy Device Sales by Application (2027-2032) & (Units) Table 124. Global Medical Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Application (2021-2026) Table 125. Global Medical Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Application (2027-2032) Table 126. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Application (2021-2026) Table 129. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Application (2027-2032) Table 130. Global Medical Neurorehabilitation Biofeedback Therapy Device Price by Application (2021-2026) & (US$/Unit) Table 131. Global Medical Neurorehabilitation Biofeedback Therapy Device Price by Application (2027-2032) & (US$/Unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Medical Neurorehabilitation Biofeedback Therapy Device Distributors List Table 135. Medical Neurorehabilitation Biofeedback Therapy Device Customers List Table 136. Medical Neurorehabilitation Biofeedback Therapy Device Industry Trends Table 137. Medical Neurorehabilitation Biofeedback Therapy Device Industry Drivers Table 138. Medical Neurorehabilitation Biofeedback Therapy Device Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Medical Neurorehabilitation Biofeedback Therapy Device Product Image Figure 5. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Medical Neurorehabilitation Biofeedback Therapy Device Market Size (2021-2032) & (US$ Million) Figure 7. Global Medical Neurorehabilitation Biofeedback Therapy Device Sales (2021-2032) & (Units) Figure 8. Global Medical Neurorehabilitation Biofeedback Therapy Device Average Price (US$/Unit) & (2021-2032) Figure 9. Conventional Product Image Figure 10. Intelligent Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Others Product Image Figure 14. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Medical Neurorehabilitation Biofeedback Therapy Device, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Medical Neurorehabilitation Biofeedback Therapy Device Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Medical Neurorehabilitation Biofeedback Therapy Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Medical Neurorehabilitation Biofeedback Therapy Device Sales by Region in 2025 Figure 20. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Region in 2025 Figure 21. North America Medical Neurorehabilitation Biofeedback Therapy Device Market Size by Country in 2025 Figure 22. North America Medical Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Country (2021-2032) Figure 23. North America Medical Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Country (2021-2032) Figure 24. United States Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Medical Neurorehabilitation Biofeedback Therapy Device Market Size by Country in 2025 Figure 28. Europe Medical Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Country (2021-2032) Figure 29. Europe Medical Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Country (2021-2032) Figure 30. Germany Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Medical Neurorehabilitation Biofeedback Therapy Device Market Size by Country in 2025 Figure 41. Asia Pacific Medical Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Medical Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Country (2021-2032) Figure 43. China Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Medical Neurorehabilitation Biofeedback Therapy Device Market Size by Country in 2025 Figure 52. South America Medical Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Country (2021-2032) Figure 53. South America Medical Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Country (2021-2032) Figure 54. Brazil Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Medical Neurorehabilitation Biofeedback Therapy Device Market Size by Country in 2025 Figure 58. Middle East and Africa Medical Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Medical Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Country (2021-2032) Figure 60. Egypt Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Medical Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Medical Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Type (2021-2032) Figure 66. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Type (2021-2032) Figure 67. Global Medical Neurorehabilitation Biofeedback Therapy Device Price (US$/Unit) by Type (2021-2032) Figure 68. Global Medical Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Application (2021-2032) Figure 69. Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Application (2021-2032) Figure 70. Global Medical Neurorehabilitation Biofeedback Therapy Device Price (US$/Unit) by Application (2021-2032) Figure 71. Medical Neurorehabilitation Biofeedback Therapy Device Value Chain Figure 72. Medical Neurorehabilitation Biofeedback Therapy Device Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Medical Neurorehabilitation Biofeedback Therapy Device Industry Opportunities and Challenges

Scope & coverage.

Types
  • Conventional
  • Intelligent
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Roche
  • Abbott
  • ARKRAY
  • Ascensia
  • B. Braun
  • BIONIME
  • GMMC Group
  • Lifescan
  • Sinocare
  • TERUMO
  • LIANFA
  • Lobeck Medical AG

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Medical Neurorehabilitation Biofeedback Therapy Device Market Size (2021-2032)
  4. 2.2.2 Global Medical Neurorehabilitation Biofeedback Therapy Device Sales (2021-2032)
  5. 2.2.3 Global Medical Neurorehabilitation Biofeedback Therapy Device Market Average Price (2021-2032)
  6. 2.3 Medical Neurorehabilitation Biofeedback Therapy Device by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Conventional
  9. 2.3.3 Intelligent
  10. 2.4 Medical Neurorehabilitation Biofeedback Therapy Device by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Medical Neurorehabilitation Biofeedback Therapy Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Medical Neurorehabilitation Biofeedback Therapy Device Sales (Units) of Manufacturers (2021-2026)
  3. 3.3 Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Medical Neurorehabilitation Biofeedback Therapy Device Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Medical Neurorehabilitation Biofeedback Therapy Device Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Medical Neurorehabilitation Biofeedback Therapy Device, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Medical Neurorehabilitation Biofeedback Therapy Device, Product Type & Application
  8. 3.8 Global Manufacturers of Medical Neurorehabilitation Biofeedback Therapy Device, Established Date
  9. 3.9 Global Medical Neurorehabilitation Biofeedback Therapy Device Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Roche
  2. 4.1.1 Roche Company Information
  3. 4.1.2 Roche Business Overview
  4. 4.1.3 Roche Medical Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Roche Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  6. 4.1.5 Roche Recent Developments
  7. 4.2 Abbott
  8. 4.2.1 Abbott Company Information
  9. 4.2.2 Abbott Business Overview
  10. 4.2.3 Abbott Medical Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Abbott Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  12. 4.2.5 Abbott Recent Developments
  13. 4.3 ARKRAY
  14. 4.3.1 ARKRAY Company Information
  15. 4.3.2 ARKRAY Business Overview
  16. 4.3.3 ARKRAY Medical Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 ARKRAY Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  18. 4.3.5 ARKRAY Recent Developments
  19. 4.4 Ascensia
  20. 4.4.1 Ascensia Company Information
  21. 4.4.2 Ascensia Business Overview
  22. 4.4.3 Ascensia Medical Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Ascensia Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  24. 4.4.5 Ascensia Recent Developments
  25. 4.5 B. Braun
  26. 4.5.1 B. Braun Company Information
  27. 4.5.2 B. Braun Business Overview
  28. 4.5.3 B. Braun Medical Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 B. Braun Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  30. 4.5.5 B. Braun Recent Developments
  31. 4.6 BIONIME
  32. 4.6.1 BIONIME Company Information
  33. 4.6.2 BIONIME Business Overview
  34. 4.6.3 BIONIME Medical Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 BIONIME Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  36. 4.6.5 BIONIME Recent Developments
  37. 4.7 GMMC Group
  38. 4.7.1 GMMC Group Company Information
  39. 4.7.2 GMMC Group Business Overview
  40. 4.7.3 GMMC Group Medical Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 GMMC Group Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  42. 4.7.5 GMMC Group Recent Developments
  43. 4.8 Lifescan
  44. 4.8.1 Lifescan Company Information
  45. 4.8.2 Lifescan Business Overview
  46. 4.8.3 Lifescan Medical Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Lifescan Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  48. 4.8.5 Lifescan Recent Developments
  49. 4.9 Sinocare
  50. 4.9.1 Sinocare Company Information
  51. 4.9.2 Sinocare Business Overview
  52. 4.9.3 Sinocare Medical Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Sinocare Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  54. 4.9.5 Sinocare Recent Developments
  55. 4.10 TERUMO
  56. 4.10.1 TERUMO Company Information
  57. 4.10.2 TERUMO Business Overview
  58. 4.10.3 TERUMO Medical Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 TERUMO Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  60. 4.10.5 TERUMO Recent Developments
  61. 4.11 LIANFA
  62. 4.11.1 LIANFA Company Information
  63. 4.11.2 LIANFA Business Overview
  64. 4.11.3 LIANFA Medical Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 LIANFA Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  66. 4.11.5 LIANFA Recent Developments
  67. 4.12 Lobeck Medical AG
  68. 4.12.1 Lobeck Medical AG Company Information
  69. 4.12.2 Lobeck Medical AG Business Overview
  70. 4.12.3 Lobeck Medical AG Medical Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Lobeck Medical AG Medical Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  72. 4.12.5 Lobeck Medical AG Recent Developments
5 Global Medical Neurorehabilitation Biofeedback Therapy Device Market Scenario by Region
  1. 5.1 Global Medical Neurorehabilitation Biofeedback Therapy Device Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Medical Neurorehabilitation Biofeedback Therapy Device Sales by Region: 2021-2032
  3. 5.2.1 Global Medical Neurorehabilitation Biofeedback Therapy Device Sales by Region: 2021-2026
  4. 5.2.2 Global Medical Neurorehabilitation Biofeedback Therapy Device Sales by Region: 2027-2032
  5. 5.3 Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Region: 2021-2032
  6. 5.3.1 Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Region: 2021-2026
  7. 5.3.2 Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Region: 2027-2032
  8. 5.4 North America Medical Neurorehabilitation Biofeedback Therapy Device Market Facts & Figures by Country
  9. 5.4.1 North America Medical Neurorehabilitation Biofeedback Therapy Device Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Medical Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2032)
  11. 5.4.3 North America Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Medical Neurorehabilitation Biofeedback Therapy Device Market Facts & Figures by Country
  16. 5.5.1 Europe Medical Neurorehabilitation Biofeedback Therapy Device Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Medical Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2032)
  18. 5.5.3 Europe Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Medical Neurorehabilitation Biofeedback Therapy Device Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Medical Neurorehabilitation Biofeedback Therapy Device Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Medical Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Medical Neurorehabilitation Biofeedback Therapy Device Market Facts & Figures by Country
  41. 5.7.1 South America Medical Neurorehabilitation Biofeedback Therapy Device Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Medical Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2032)
  43. 5.7.3 South America Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Medical Neurorehabilitation Biofeedback Therapy Device Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Medical Neurorehabilitation Biofeedback Therapy Device Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Medical Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Medical Neurorehabilitation Biofeedback Therapy Device Sales by Type (2021-2032)
  2. 6.1.1 Global Medical Neurorehabilitation Biofeedback Therapy Device Sales by Type (2021-2032) & (Units)
  3. 6.1.2 Global Medical Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Type (2021-2032)
  4. 6.2 Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Type (2021-2032)
  5. 6.2.1 Global Medical Neurorehabilitation Biofeedback Therapy Device Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Medical Neurorehabilitation Biofeedback Therapy Device Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Medical Neurorehabilitation Biofeedback Therapy Device Sales by Application (2021-2032)
  2. 7.1.1 Global Medical Neurorehabilitation Biofeedback Therapy Device Sales by Application (2021-2032) & (Units)
  3. 7.1.2 Global Medical Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Application (2021-2032)
  4. 7.2 Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue by Application (2021-2032)
  5. 7.2.1 Global Medical Neurorehabilitation Biofeedback Therapy Device Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Medical Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Medical Neurorehabilitation Biofeedback Therapy Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Medical Neurorehabilitation Biofeedback Therapy Device Value Chain Analysis
  2. 8.1.1 Medical Neurorehabilitation Biofeedback Therapy Device Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Medical Neurorehabilitation Biofeedback Therapy Device Production Mode & Process
  5. 8.2 Medical Neurorehabilitation Biofeedback Therapy Device Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Medical Neurorehabilitation Biofeedback Therapy Device Distributors
  8. 8.2.3 Medical Neurorehabilitation Biofeedback Therapy Device Customers
9 Global Medical Neurorehabilitation Biofeedback Therapy Device Analyzing Market Dynamics
  1. 9.1 Medical Neurorehabilitation Biofeedback Therapy Device Industry Trends
  2. 9.2 Medical Neurorehabilitation Biofeedback Therapy Device Industry Drivers
  3. 9.3 Medical Neurorehabilitation Biofeedback Therapy Device Industry Opportunities and Challenges
  4. 9.4 Medical Neurorehabilitation Biofeedback Therapy Device Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst